“Cyclophosphamide and fluorouracil combined with mitoxantrone versus doxorubicin for breast cancer: superiority of doxorubicin.”, J Clin Oncol, vol. 15, no. 5, pp. 1897-905, 1997.
, “No evidence for lipid peroxidation in severe preeclampsia”, Am J Obstet Gynecol, vol. 185, pp. 572-8, 2001.
, “Descriptions of benefits and risks in consent forms for Phase 1 oncology trials”, N Engl J Med, vol. 347, pp. 2134-2140, 2002.
, “Anemia and Growth Status in Pediatric Patients Receiving Maintenance Dialysis after a Failed Renal Transplant Course: An NAPRTCS Report”, Pediatr Transplant, vol. 11, pp. 201-204, 2007.
, ,
“The effect of recipient-specific surgical issues on outcome of liver transplantation in biliary atresia.”, Am J Transplant, vol. 8, no. 6, pp. 1197-204, 2008.
, “Factors Related to Long-Term Renal Transplant Function in Children”, Pediatr Nephrol, vol. 23, pp. 1149-1155, 2008.
, “Liver retransplantation in children: a SPLIT database analysis of outcome and predictive factors for survival.”, Am J Transplant, vol. 8, no. 2, pp. 386-95, 2008.
, “Outcomes of Kidney Transplantation in Children with Nephronophthisis: An Analysis of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) Registry”, Pediatr Transplant, vol. 12, pp. 878-882, 2008.
, “Progression to End-stage Renal Disease in Children with Vesicoureteral Reflux (VUR): Insights from an Analysis of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) Database”, in AAP, Boston, MA, 2008.
, “Recombinant Growth Hormone Use Pretransplant and Risk for Post-Transplant Lymphoproliferative Disease–a Report of the NAPRTCS”, Pediatr Transplant, vol. 12, pp. 689-695, 2008.
, “Anemia and Risk of Hospitalization in Pediatric Chronic Kidney Disease”, Clin J Am Soc Nephrol, vol. 4, pp. 48-56, 2009.
, “Association Between Clinical Risk Factors and Progression of Chronic Kidney Disease in Children”, Clin J Am Soc Nephrol, vol. 5, pp. 2172-2179, 2010.
, “Cross-sectional Analysis of Health Related Quality of Life in Pediatric Liver Transplant Recipients”, J Pediatr, vol. 156, pp. 270-276.e271, 2010.
, “Glomerular Filtration Rate Following Pediatric Liver Transplantation–the Split Experience”, Am J Transplant., vol. 10, pp. 2673-2682, 2010.
, “Glomerular filtration rate following pediatric liver transplantation--the SPLIT experience.”, Am J Transplant, vol. 10, no. 12, pp. 2673-82, 2010.
, “Mortality Risk in Children after Renal Allograft Failure: A NAPRTCS Study”, Pediatr Nephrol, vol. 25, pp. 2517-2522, 2010.
, “Risk for Anemia in Pediatric Chronic Kidney Disease Patients: A Report of NAPRTCS”, Pediatric Nephrology, vol. 25, pp. 1699-1706, 2010.
, “Variables affecting estimated glomerular filtration rate after renal transplantation in children: a NAPRTCS data analysis.”, Pediatr Transplant, vol. 14, no. 2, pp. 288-94, 2010.
, “Variables Affecting Estimated Glomerular Filtration Rate after Renal Transplantation in Children: A NAPRTCS Data Analysis”, Pediatr Transplant, vol. 14, pp. 288-294, 2010.
, “Weight and Height Changes and Factors Associated with Greater Weight and Height Gains After Pediatric Renal Transplantation: A NAPRTCS Study”, Transplantation, vol. 89, pp. 1103-1112, 2010.
, “Cognitive and Academic Outcomes after Pediatric Liver Transplantation: Functional Outcomes Group (FOG) Results”, Am J Transplant, vol. 11, pp. 303-311, 2011.
, “Cognitive and academic outcomes after pediatric liver transplantation: Functional Outcomes Group (FOG) results.”, Am J Transplant, vol. 11, no. 2, pp. 303-11, 2011.
, “Good Outcome of Kidney Transplants in Recipients of Young Donors: A NAPRTCS Data Analysis”, Pediatr Transplant, vol. 15, pp. 167-171, 2011.
, “Health-related quality of life in pediatric liver transplant recipients compared with other chronic disease groups”, Pediatr Transplant, vol. 15, pp. 245-253, 2011.
,